Skip to content
10-Q

Quarterly Report

MOSAIC IMMUNOENGINEERING, INC. CPMV

0001683168-26-004152

← back to feed
Filed
May 20, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 20, 2026 7.24M sh
Shares Diluted Q1 2026 · Mar 31, 2026 7.24M sh
Shares Diluted Q1 2026 · Mar 31, 2025 7.24M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$3.55K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$29.09K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $72
Cash And Equivalents Q1 2026 · Dec 31, 2025 $3.62K
Stockholders Equity Q1 2026 · Mar 31, 2026 −$7.65M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$7.48M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$6.97M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$6.79M
Current Liabilities Q1 2026 · Mar 31, 2026 $6.18M
Current Liabilities Q1 2026 · Dec 31, 2025 $6.03M
Total Liabilities Q1 2026 · Mar 31, 2026 $7.66M
Total Liabilities Q1 2026 · Dec 31, 2025 $7.5M
Current Assets Q1 2026 · Mar 31, 2026 $9.83K
Current Assets Q1 2026 · Dec 31, 2025 $19.88K
Total Assets Q1 2026 · Mar 31, 2026 $9.83K
Total Assets Q1 2026 · Dec 31, 2025 $19.88K
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.02
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.03
Eps Basic Q1 2026 · Mar 31, 2026 −$0.02
Eps Basic Q1 2026 · Mar 31, 2025 −$0.03
Rd Expense Q1 2026 · Mar 31, 2026 $15.88K
Rd Expense Q1 2026 · Mar 31, 2025 $15.8K
Net Income Q1 2026 · Mar 31, 2026 −$175.35K
Net Income Q1 2026 · Mar 31, 2025 −$181.32K
Operating Income Q1 2026 · Mar 31, 2026 −$154.8K
Operating Income Q1 2026 · Mar 31, 2025 −$174.77K